Curofy raises Rs 12 cr in a pre Series A funding
Advertisement
911 India Healthcare Pvt Ltd running the doctors community app- Curofy is said to have raised Rs 12 crore from US-based venture capital firm RoundGlass Partners in a pre-series A funding.
The social network will deploy the money for product development, marketing and hiring resources, said co-founder Nipun Goyal. " We are currently a focused team of 20 people. With the funding, we plan to double the team in the next two three months. We also plan to take a panel of specialists on our board who will become the face of each speciality." Said Nipun to Medical Dialogues
Apart from expansion of the team, Curofy also plans to make the app more doctor centric and user friendly." We have various checks and balances in place so that only doctors can become a part of the curofy social networking system. Moreover, our focus from now on would be to make the interface most user centric so that doctors can easily access the articles based on their interests and liking."
The social network will deploy the money for product development, marketing and hiring resources, said co-founder Nipun Goyal. " We are currently a focused team of 20 people. With the funding, we plan to double the team in the next two three months. We also plan to take a panel of specialists on our board who will become the face of each speciality." Said Nipun to Medical Dialogues
Apart from expansion of the team, Curofy also plans to make the app more doctor centric and user friendly." We have various checks and balances in place so that only doctors can become a part of the curofy social networking system. Moreover, our focus from now on would be to make the interface most user centric so that doctors can easily access the articles based on their interests and liking."
Talking about RoundGlass Partners Goyal told VCCircle. “They (RoundGlass Partners) are an extremely seasoned team that can provide us with both financial support and deep healthcare expertise. Over the last few months, we have monitored and tracked data patterns from daily activities of our users. We will use this data to further personalise our app and offer improved experience to our customers."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.